Results 31 to 40 of about 10,714,967 (215)

Recurrent Ameloblastoma: Clinical Manifestation and Disease-Free Survival Rate

open access: yesJournal of Oncology, 2022
Objectives. Ameloblastoma is a slow-growing epithelial odontogenic neoplasm of the jaws with a high recurrence rate. The main treatment strategies for this lesion are radical or conservative surgical approaches. The aim of the present study was to analyze clinical presentations, histological types, and treatment strategies of recurrent ameloblastoma ...
Andrii Hresko   +6 more
openaire   +4 more sources

Survival Outcomes and Prognostic Factors in Salivary Gland Cancers Treated by Surgery and Adjuvant Radiotherapy

open access: yesNamık Kemal Tıp Dergisi, 2021
Aim:To evaluate the variables affecting prognostic factors in patients with salivary gland cancer who have received surgery followed by radiotherapy (RT).Materials and Methods:Fifty-three patients with major and minor salivary gland cancer were treated ...
Mürsel DÜZOVA, Tahir Sedat TURKAN
doaj   +1 more source

Disease-free survival (DFS) among 30 patients with triple-negative breast cancer (TNBC).

open access: yes, 2022
Disease-free survival (DFS) among 30 patients with triple-negative breast cancer (TNBC).
Dalia O. Mohamed (11978982)   +6 more
core   +1 more source

Disease-free survival and overall survival of cervical cancer patients after radical hysterectomy and pelvic lymph-node dissection [PDF]

open access: yes, 2020
Introduction: Radical Hysterectomy and Pelvic Lymph-Node Dissection (RH-PLND), with or without Neoadjuvant Chemotherapy (NAC) nor Adjuvant Therapy (AT), is still the treatment of choice in stages IB-IIB of cervical cancer due to limited access to ...
Ardi Eko Marsanto, -   +2 more
core   +1 more source

MRPL27 contributes to unfavorable overall survival and disease-free survival from cholangiocarcinoma patients [PDF]

open access: yesInternational Journal of Medical Sciences, 2021
Objective: This study aimed to investigate the roles of MRPL27 in survival from cholangiocarcinoma patients in The Cancer Genome Atlas (TCGA) database. Methods: In TCGA-CHOL profile, MRPL27 gene expression and clinical data were obtained. Cox regression models were used to evaluate the potential links between MRPL27 and cholangiocarcinoma survival ...
Zhuang, Liping   +2 more
openaire   +2 more sources

Multivariate Cox Survival Analysis - Disease-free survival.

open access: yes, 2013
Multivariate Cox Survival Analysis - Disease-free survival.
Hans-Juergen Holzhausen (303448)   +18 more
core   +1 more source

LINC00309 is associated with short disease-free survival in breast cancer [PDF]

open access: yesCancer Cell International, 2019
Long non-coding RNAs play an important role in breast cancer. Even with adjuvant hormone therapy, patients with estrogen receptor positive breast cancer can present with recurrences and distant metastases. We investigated whether the expression of a novel long non-coding RNA LINC00309 can predict the outcome of breast cancer, especially for hormone ...
Sheng Huang   +12 more
openaire   +3 more sources

Disease-Free Survival.

open access: yes, 2014
Disease-Free Survival.
Stanley L. Liauw (507756)   +4 more
core   +1 more source

Cyclin D3 predicts disease-free survival in breast cancer [PDF]

open access: yesCancer Cell International, 2015
Abstract Background Cyclin D3, which induces progression through the G1 phase of the cell cycle, is a regulator of Cyclin-dependent kinases 4 and 6. Previous studies revealed that abnormal expression of Cyclin D3 was found in many different cancers.
Chi, Yayun   +5 more
openaire   +2 more sources

Disease-free survival as a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a meta-analysis of 20 randomized controlled trials

open access: yesBMC Cancer, 2020
Background We aimed to assess whether disease-free survival (DFS) could serve as a reliable surrogate endpoint for overall survival (OS) in adjuvant trials of pancreatic cancer.
Run-Cong Nie   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy